Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System

Conditions:   Pulmonary Embolism;   Venous Thromboembolism;   Deep Vein Thrombosis
Intervention:  
Sponsor:   Volcano Corporation
Not yet recruiting - verified April 2015

Apixaban for Treatment of Embolic Stroke of Undetermined Source

Condition:   Embolic Stroke
Interventions:   Drug: Apixaban;   Drug: Aspirin
Sponsor:   University Hospital Tuebingen
Not yet recruiting - verified April 2015

Location of Lower Extremity Deep Vein Thrombosis by Emergency Physicians Using Portable Compression Ultrasonography

Condition:   Deep Vein Thrombosis
Interventions:   Procedure: portable venous compression ultrasonography;   Procedure: venous compress ultrasonography;   Procedure: Doppler ultrasound of the lower limbs
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Recruiting - verified April 2015

AOP2014 in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.

Condition:   Polycythemia Vera
Intervention:   Drug: Pegylated-Proline-interferon alpha-2b
Sponsors:   AOP Orphan Pharmaceuticals AG;   PharmaEssentia (Co-Sponsor for USA)
Recruiting - verified April 2015

Osteopathic Treatment and Deep Vein Thrombosis (DVT)

Condition:   Deep Vein Thrombosis (DVT)
Intervention:   Other: Osteopathic Treatment
Sponsor:   Capital District Health Authority, Canada
Recruiting - verified April 2015

Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)

Conditions:   Wounds and Injuries;   Acute Coagulopathy
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsors:   National Trauma Research Institute;   National Health and Medical Research Council, Australia
Recruiting - verified April 2015

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE

Conditions:   Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE)
Intervention:  
Sponsor:   Johannes Gutenberg University Mainz
Recruiting - verified April 2015

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified April 2015

Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation

Conditions:   Deep Vein Thrombosis;   Venous Thromboembolism
Intervention:   Device: Thrombectomy
Sponsor:   Ottawa Hospital Research Institute
Terminated - verified April 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting - verified April 2015

Norwegian Intensive Care Unit Dalteparin Effect Study

Conditions:   Acute Kidney Injury;   Deep Venous Thrombosis
Intervention:   Device: Continuous venovenous hemodialysis
Sponsors:   Oslo University Hospital;   University of Oslo
Recruiting - verified April 2015

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Conditions:   Deep Vein Thrombosis;   Venous Thrombosis
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care
Sponsor:   Bayer
Active, not recruiting - verified April 2015

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Conditions:   Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:  
Sponsors:   Ottawa Hospital Research Institute;   Heart and Stroke Foundation of Ontario
Active, not recruiting - verified April 2015

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Conditions:   Thrombosis;   Heparin-induced Thrombocytopenia
Intervention:   Drug: Fondaparinux
Sponsor:   Dr. Guy A. Young (Children's Hospital Los Angeles)
Completed - verified October 2011

Odiparcil For The Prevention Of Venous Thromboembolism

Conditions:   Fibrillation, Atrial;   Deep Vein Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism
Interventions:   Drug: Odiparcil;   Drug: Warfarin;   Drug: Coumadin
Sponsor:   GlaxoSmithKline
Completed - verified April 2015

Get CardioSmart

You're Invited